Inotiv (STU:BS50) Operating Cash Flow per Share : €1.19 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inotiv Operating Cash Flow per Share?

Inotiv's operating cash flow per share for the three months ended in Mar. 2024 was €0.60. Inotiv's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was €1.19.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 109.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Inotiv's Operating Cash Flow per Share or its related term are showing as below:

STU:BS50' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -27.4 Med: 3.4 Max: 109
Current: 109

During the past 13 years, Inotiv's highest 3-Year average Operating Cash Flow per Share Growth Rate was 109.00% per year. The lowest was -27.40% per year. And the median was 3.40% per year.

STU:BS50's 3-Year OCF Growth Rate is ranked better than
98.31% of 177 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.8 vs STU:BS50: 109.00

Inotiv Operating Cash Flow per Share Historical Data

The historical data trend for Inotiv's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inotiv Operating Cash Flow per Share Chart

Inotiv Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.16

0.10

0.66

-0.22

1.02

Inotiv Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.47	0.13	0.69	-0.23	0.60

Competitive Comparison of Inotiv's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Inotiv's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inotiv's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Inotiv's Price-to-Operating-Cash-Flow falls into.

Inotiv Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Inotiv's Operating Cash Flow per Share for the fiscal year that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (A: Sep. 2023 )	=	Cash Flow from Operations (A: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (A: Sep. 2023 )
	=	26.126	/	25.641
	=	1.02

Inotiv's Operating Cash Flow per Share for the quarter that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	15.565	/	25.831
	=	0.60

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.19

Inotiv Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Inotiv's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Inotiv (STU:BS50) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inotiv Inc (STU:BS50) » Definitions » Operating Cash Flow per Share

Comparable Companies

STIM FONR BNR ACRS PRPH VNRX MDXH BDSX BIOQ PSNL TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

NOTV:USA

Address

2701 Kent Avenue, West Lafayette, IN, USA, 47906

Website

https://www.inotivco.com

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

Inotiv (STU:BS50) Headlines

No Headlines